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The eﬀect of a membrane-mimicking environment
on the interactions of Cu2+ with an amyloidogenic
fragment of chicken prion protein†
Aleksandra Hecel,a Sara Draghi,b Daniela Valensin *b and Henryk Kozlowskic
Prion proteins (PrP) from diﬀerent species have the ability to tightly bind Cu2+ ions. Copper coordination
sites are located in the disordered and ﬂexible N-terminal region which contains several His anchoring
sites. Among them, two His residues are found in the so called amyloidogenic PrP region which is
believed to play a key role in the process leading to oligomer and ﬁbril formation. Both chicken and
human amyloidogenic regions have a hydrophobic C-terminal region rich in Ala and Val amino acids.
Recent ﬁndings revealed that this domain undergoes random coil to α-helix structuring upon interaction
with membrane models. This interaction might strongly impact metal binding abilities either in terms of
donor sets or aﬃnity. In this study we investigated Cu2+ interaction with an amyloidogenic fragment,
chPrP105–140, derived from chicken prion protein (chPrP), in diﬀerent solution environments. The be-
havior of the peptide and its metal complexes was analyzed in water and in the presence of negative and
positive charged membrane mimicking environments formed by sodium dodecyl sulfate (SDS) and
dodecyl trimethyl ammonium chloride (DTAC) micelles. The metal coordination sphere, the metal binding
aﬃnity and stoichiometry were evaluated by combining spectroscopic and potentiometric methods.
Finally we compare copper(II) interactions with human and chicken amyloidogenic fragments. Our results
indicate that the chicken amyloidogenic fragment is a stronger copper ligand than the human amyloido-
genic fragment.
Introduction
Prion proteins (PrPs) have been involved in diverse mamma-
lian-TSEs: human (Creutzfeldt–Jakob disease, CJD) and animal
neurodegenerative diseases (bovine spongiform encephalo-
pathy, BSE). Their biological functions are still not well under-
stood, nevertheless prion proteins may play an important role
in copper homeostasis/transport and antioxidant activity in
the brain.1,2 Prion disorders are associated with conformation-
al changes of the cellular prion protein (PrPC) into a patho-
genic, insoluble, protease-resistant and β-sheet rich isoform
(Scrapie PrP or PrPSc), whose biological function is still under
debate.3–8 PrPC–PrPSc conversion is characterized by the for-
mation of neurotoxic oligomers and amyloid fibrils.
It is well accepted that Cu2+ ions bind to the cellular form
of human PrP (hPrPC) in vivo.9 Four Cu2+ ions are bound
within the His-containing sequence, –PHGGGWGQ– that is
repeated four times between residues 60–91.10–16 Two
additional copper binding sites are located at His96 and
His111, outside the octarepeat domain.17–25 This region,
encompassing residues from 91 to 127 in hPrPC, seems to be
essential for amyloid formation and infectivity of prion
disease.26,27 Prion is not only a characteristic protein for
mammals, it is also found in many other species including
avians, fishes, reptiles and amphibians. Chicken prion protein
(chPrP) was extracted from the brain of domestic fowl as a
homolog of hPrP.28 chPrP shows around 30% identity with
mammalian prion proteins but exhibits a very similar 3D struc-
ture.29 Despite low sequence homology, the essential features
of mammalian prion proteins are also conserved in avian
PrP.30
chPrP is able to interact with Cu2+ through the tandem
hexapeptide (residues 53–94) and amyloidogenic (residues
105–140) regions. The repeats consist of –PHNPGY– sequences
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which anchor copper via His imidazoles.10,31–38 The amyloido-
genic domain of chPrP shares several common features with
hPrP91–127:39,40
i. They both have two His residues spaced by almost the
same number of amino acids. In chPrP they correspond to
His110 and His124 (Scheme 1).
ii. They have an identical hydrophobic tail (residues
113–127 and 126–140, in hPrP and chPrP respectively) of 15
amino acids rich in Ala and Gly residues (Scheme 1).
iii. They both bind two copper ions at each His residue.
Either 3N1O or 4N complexes are formed at physiological pH.
The formation of 3N {Nim, 2N
−} or 4N {Nim, 3N
−} copper
species is strongly dependent on the pH value and the ana-
lyzed peptide sequences. Generally, it is well accepted that an
equilibrium between 3N1O and 4N complexes is present at
neutral pH for the hPrP91–127 system.17,18,41,42 In contrast, for
chPrP105–140 at physiological pH, 4N species only are
detected.39
It is well known that the hydrophobic 112–125 region of
hPrP undergoes random coil to α-helix transition in the pres-
ence of membrane like environments (surfactant or lipid
micelles) and structuring solvents.43–47 Similarly to what
happens to other amyloidogenic proteins, like Aβ and αS, this
structural rearrangement strongly impacts Cu2+ binding
modes in terms of both donor atoms and aﬃnity.47,48 As we
recently demonstrated, the interaction of hPrP91–127 with
anionic micelles facilitates simultaneous copper coordination
to both His96 and His111, which on the other hand behaves
as separate metal anchoring sites in the absence of micelle
environment.47 Since chPrP105–140 contains the same
C-terminal tail (Scheme 1) analogous structural changes are
expected when this fragment interacts with micelles. In
addition, this behaviour might aﬀect Cu2+ interaction with
chPrP105–140 as well.
In this work we have investigated Cu2+ binding features of
the chPrP fragment spanning residues 105–140 in the presence
of micelles formed by anionic sodium dodecyl sulfate (SDS)
and cationic dodecyl trimethyl ammonium chloride (DTAC)
surfactants. We focused on exploring the impact of the hydro-
phobic tail on conformation, Cu2+ binding aﬃnity and tertiary
structure of Cu2+ complexes with the amyloidogenic chPrP
fragment. Copper coordination to human and avian systems
was compared as well.
Experimental
Peptide synthesis and purification
The peptide was synthesized on an Activotec Activo-P11 auto-
mated peptide synthesizer with Fmoc-protected amino acids
using 9-fluorenylmethoxycarbonyl (Fmoc) chemistry.49 We
used a Rink-Amide resin as a solid support so that the
obtained peptides are amidated at the C-terminus. The
N-terminus was acetylated with a solution of 1.0 M acetic anhy-
dride and 0.4 M diisopropylethylamine (DIEA) in N,N-di-
methylformamide (DMF). Cleavage from the resin was
performed by using a 90% trifluoroacetic acid (TFA) solution
containing 5% thioanisole, 2% anisole and 3% ethanedithiol
for 120 min. The cleaved peptide was precipitated with cold
diethyl ether, dissolved in water and lyophilized. The solid was
then dissolved in 10% acetic acid and purified by high-
performance liquid chromatography (HPLC) on a preparative
C18 column (Varian Pursuit VRs C 18) by using Varian Prostar
HPLC. Peptide purification was performed with a semi-linear
gradient of 0.1% TFA in water to 0.1% TFA in 9 : 1 CH3CN–H2O
over 45 min. Electrospray ionization mass spectrometry
(ESI-MS) was used to verify the molecular mass of the syn-
thesized peptide.
Potentiometric measurements
Potentiometric measurements were performed at 298 K under
an argon atmosphere using a MOLSPIN pH-meter. Stability
constants for both protons and Cu2+ complexes were calcu-
lated from titrations carried out over the pH range of 2–11. A
total volume of 1.5 ml was used for each measurement. NaOH
additions were performed by means of a 0.5 ml micrometer
syringe. Before each measurement, the electrode was cali-
brated by titrating HCl (4.0 mM) in 40 mM SDS, 100 mM DTAC
or 100 mM KCl ionic strength respectively, with a strong base.
The preparation of surfactant solutions should be per-
formed carefully. It is very important to not shake and stir the
solution during dissolution in order to avoid foaming of the
solution. The dissolving process of surfactants was performed
by using Ultrasonic Baths at around 60 °C. The stock solution
(1 M SDS or 1 M DTAC) in water was prepared and only a few
microliters were added to the samples in order to achieve a
final concentration of 40 mM SDS or 100 mM DTAC.
Ligand and metal complex titrations were carried out in
4.0 mM HCl water solutions containing 0.1 M KCl or 40 mM
SDS or 100 mM DTAC ionic strength. During potentiometric
measurements an appropriate stirring speed (medium or low)
was selected to avoid foaming of the samples. For measure-
ments in water we used a Mettler Toledo InLab semi-micro
electrode. The same electrode was not employed for solutions
containing SDS and DTAC, since they both form insoluble
salts with K+ ions. For these reasons the KCl electrolyte in the
calomel electrode was exchanged for NaCl.47,50 The ligand con-
centration was 0.5 mM and the Cu2+ to ligand molar ratio was
1 : 1.2. The SUPERQUAD program was used for stability con-
stant calculations.51 Reported log β values refer to the overall
equilibria:
pCuþ qHþ rL $ CupHqLr ð1Þ
β ¼ ½CupHqLr ½Cup½Hq½Lr ð2Þ
Scheme 1 Primary sequence of hPrP91–127 and chPrP105–140.
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charges are omitted for clarity; log Kstep values refer to the pro-
tonation process:
CupHq1Lr þH $ CupHqLr ð3Þ
(charges omitted; p might also be 0). The speciation diagrams
were plotted with the HYSS 2006 program.52
UV-Vis measurements
The absorption spectra were recorded on a Cary 300 Bio
spectrophotometer in the 800–200 nm range. Measurements
were performed on a 3.0 ml sample in a quartz cell of 1 cm
path length. The final peptide concentration was 1.0 mM, the
metal to ligand molar ratio was 1 : 1.2. The samples were pre-
pared in 4.0 mM HCl water solutions containing 0.1 M KCl or
40 mM SDS or 100 mM DTAC ionic strength. Data were pro-
cessed using Origin 7.0.
Circular dichroism measurements
Circular dichroism (CD) spectroscopy experiments were per-
formed on a spectropolarimeter Jasco J-715 at 298 K in a
0.1 cm and 1 cm quartz cell. The spectral range was 185–300
and 200–800 nm, respectively. The samples were prepared in
4.0 mM HCl water solutions containing 0.1 M KCl or 40 mM
SDS or 100 mM DTAC ionic strength. Ligand concentration
was 1.0 mM and Cu2+ to ligand molar ratio was 1 : 1.2. The
direct CD measurements (θ) were converted to mean residue
molar ellipticity (Δε) using Jasco SpectraManager.
EPR spectroscopy
The EPR spectra were recorded in liquid nitrogen on a Bruker
ELEXSYS E500 CW-EPR spectrometer at X-band frequency (9.5
GHz) and equipped with an ER 036TM NMR Teslameter and
E41 FC frequency counter. The ligand concentration was
1 mM and the Cu2+ to ligand molar ratio was 1 : 1.2. Ethylene
glycol (25%) was used as a cryoprotectant for EPR measure-
ments in water solution. The EPR parameters were obtained by
simulation of plots using the Bruker WinEPR SimFonia
program.
NMR measurements
NMR experiments were carried out at 298 K using a 600 MHz
Bruker Advance spectrometer. NMR spectra were processed
with TopSpin 3.6 software and analyzed with the program
CARA.53 The suppression of the residual water signal was
achieved by excitation sculpting,54 using a selective 2 ms long
square pulse on water. Proton resonance assignment of
chPrP105–140 was achieved by 2D NMR analysis, 1H–1H
TOCSY and NOESY. The peptide was dissolved in 20 mM phos-
phate buﬀer at pH 7.4 with 10% of D2O and 40 mM SDS. The
final peptide concentration was 0.8 mM. The desired concen-
trations of Cu2+ ions and SDS were obtained by using stock
solutions of Cu(NO3)2 and deuterated SDS (Sigma Chemical
Co.) in D2O.
Structure calculation
NOE cross peaks in 2D 1H–1H NOESY spectra acquired on apo
chPrP105–140 at 298 K were integrated with the CARA program
and converted into an inter-nuclear distance list with the
routine CALIBA of the program package DYANA.55 An ensem-
ble of 300 structures were obtained by the standard protocol of
simulated annealing in torsion angle space implemented in
DYANA (using 10 000 steps). No dihedral angle restraints and
no hydrogen bond restraints were applied. The final structures
were analyzed using the program MOLMOL.56
Results and discussion
Thermodynamic stability constants of Cu2+–chPrP complexes
The thermodynamic parameters for chPrP105–140 protonation
in water, SDS and DTAC solutions are collected in Table 1. The
obtained data indicate that chPrP105–140 behaves as H7L acid.
The seven protonation constants correspond to consecutive
proton binding to ε-amino groups of four Lys (Lys113, Lys116,
Lys119 and Lys123), the phenolic group of Tyr109 and imid-
azole nitrogens of His110 and His124.
Potentiometric titrations of Cu2+–chPrP complexes in water
and in the presence of SDS and DTAC micelles were carried
out to evaluate the corresponding complex formation con-
stants and the distribution diagrams (Table 2, Fig. 1). The data
shown in Table 2 indicate that the same species are formed
independently in the investigated environment. On the other
hand, stability constants distinctly diﬀer. CuH6L species
results from His imidazole deprotonation. The diﬀerence
Table 1 Thermodynamic parameters for protonation of the
chPrP105–140 fragment at 298.2 K in water (A), SDS (B) and DTAC solu-
tions (C). Standard deviation on the last signiﬁcant is in parenthesis
log β log K log β*
A
HL 10.99(2) 10.99
H2L 21.49(1) 10.50
H3L 31.56(2) 10.07
H4L 41.30(1) 9.74
H5L 50.45(2) 9.15
H6L 56.94(2) 6.49
H7L 62.62(3) 5.72
B
H2L 22.97(5)
H3L 33.99(2) 11.02
H4L 44.86(3) 10.87
H5L 54.27(3) 9.41
H6L 62.14(4) 7.87
H7L 69.07(4) 6.93
C
HL 10.75(2) 10.75
H2L 20.57(2) 9.82
H3L 30.43(3) 9.86
H4L 39.95(1) 9.52
H5L 48.95(3) 9.00
H6L 55.35(3) 6.40
H7L 61.04(4) 5.69
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between log K* values (log β*CuH6L − log β*H6L) measured in
water (4.41), SDS (5.36) and DTAC (3.87) is explained by the
fact that the imidazole nitrogen atoms are more and less basic
in SDS and in DTAC solutions, respectively. In addition, imid-
azole protonation constants greatly diﬀer when metal bound
and free peptides are compared. This behavior supports His
binding to Cu2+ in all three cases. Further deprotonation
results in the formation of CuH5L species in which two imid-
azole nitrogen atoms of His residues are deprotonated. The
most significant diﬀerences are observed for log β* values.
log β* of CuH6L (5.36) and CuH5L (7.44) in SDS (Table 2B)
diﬀers by more than two units, while they are much closer for
water and DTAC systems. These values strongly indicate that
the Cu2+ ion coordinates to both imidazoles in the case of
SDS, while only one His is bound to copper in water and DTAC
solutions.
In addition, the distribution diagrams reported in Fig. 1
clearly show that:
(i) the pH values at which CuH4L, CuH3L, CuH2L and CuHL
predominates are the highest ones in the presence of SDS
micelles;
(ii) CuH5L exists as main species at pH 6.0 for SDS systems
only and
(iii) DTAC micelles do not significantly influence the specia-
tion profiles observed in water in the pH range of 4.0–9.0.
Influence of SDS and DTAC micelles on chPrP105–140
conformation
In water solution, apo and Cu2+ bound chPrP105–140 systems
have CD spectra characterized by a strong negative absorption
band centered around 197–200 nm, typical of random coil con-
formation (Fig. 1S†). In the presence of SDS micelles, CD
spectra have two strong negative absorption bands at 207 and
222 nm, respectively, strongly indicating α-helix structuring of
the peptide backbone (Fig. 2).
Table 2 Thermodynamic parameters for Cu2+ complex formation of
the chPrP105–140 fragment at 298.2 K in water (A), SDS (B) and DTAC
solutions (C). Standard deviation on the last signiﬁcant is in parenthesis
log β log K log β* a
A
CuH6L 61.35(5) 4.41
CuH5L 55.81(7) 5.51 5.36
CuH4L 50.87(4) 4.94
CuH3L 44.81(4) 6.06
CuH2L 38.42(5) 6.39
CuHL 30.22(8) 8.20
CuL 20.38(11) 9.84
CuH−1L 10.76(9) 9.62
CuH−2L 0.44(11) 10.32
B
CuH6L 67.50(4) 5.36
CuH5L 61.71(3) 5.79 7.44
CuH4L 55.50(4) 6.21
CuH3L 48.71(4) 6.79
CuH2L 40.84(6) 7.87
CuHL 31.95(7) 8.89
CuL 21.88(8) 10.07
CuH−1L 10.86(9) 11.02
CuH−2L 0.10(10) 10.76
C
CuH6L 59.22(9) 3.87
CuH5L 53.71(9) 5.51 4.76
CuH4L 48.60(5) 5.11
CuH3L 42.10(6) 6.50
CuH2L 35.90(5) 6.20
CuHL 28.12(8) 7.78
CuL 18.82(9) 9.30
CuH−2L −0.92(10)
a A log β* = log β(CuHjL) − log β(HnL) (where the index j corresponds to
the number of protons in the coordinated ligand to the metal ion and
n corresponds to the number of protons coordinated to the ligand).
Fig. 1 Species distribution diagram for Cu2+–chPrP105–140 complexes
(A) in water, (B) SDS and (C) DTAC solution at 1 : 1.2 Cu2+/peptide ratio;
T = 298.2; cpeptide = 5 × 10
−4 M.
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In order to better investigate the conformational behavior
of the chPrP105–140 fragment in the presence of SDS, NMR
studies were carried out with the final aim to determine the
3D structure. As expected, no trivial correlations were detected
in NOESY spectra, strongly demonstrating the presence of an
α-helix structure (Fig. 3). A structural preliminary analysis was
performed by evaluating the set of inter proton distances cal-
culated from NOEs which clearly anticipates α-helix elements
between residues 120–131 (Fig. 2S†).
The obtained distances were then used as constraints for
simulated annealing calculations by using the DYANA
program. The best 20 structures are shown in Fig. 4. As
expected residues 120–131 adopt a nice α helical confor-
mation, while, the N-terminal part is still flexible and dis-
ordered. Similarly to what happened for hPrP, these structural
changes strongly aﬀect His positions as well: His110 (shown in
blue) has a completely random rearrangement, while His124
(cyan) being inside the α-helix has its own defined orientation.
By considering that hPrP and chPrP amyloidogenic
domains share the same hydrophobic tail and taking into
account that this region is responsible for the α-helix structur-
ing upon interaction with SDS, we expected that the two pep-
tides possess very similar structures. However, their compari-
son indicates that the α-helix in chPrP includes His124 as well,
while it starts immediately after His111 in hPrP. This could be
due to the presence of two point mutations. In fact, the two
Met present in hPrP are substituted by Phe and Val residues in
chPrP (Scheme 1). Besides that, the two α-helixes are very
similar (Fig. 3S†).
The eﬀect of DTAC micelles was also investigated. Both
chPrP105–140 and its copper complexes (Fig. 4S†) show pre-
valent random coil conformation in the pH range of 3–8.
Starting from acid pH to pH 8.7 we observed a gradual shift of
the CD band at 197 nm to a longer wavelength (203 nm). At
pH 9.2, CD spectra begin to change dramatically to assume
typical features of α-helix spectra at pH higher than 10. As
Fig. 2 CD spectra of (A) chPrP105–140 and (B) Cu2+–chPrP105–140 in
40 mM SDS solutions. 0.1 cm quartz cell, T = 298.2 K; concentration of
peptide = 1 × 10−4 M, 1 : 1.2 Cu2+/peptide ratio.
Fig. 3 Selected region of the 1H–1H NOESY spectrum, showing NH–
NH dipolar connectivities.
Fig. 4 The best 20 NMR structures obtained for chPrP105–140 frag-
ments in the presence of 40 mM SDS. The structures are ﬁtted on the
120–131 backbone residues and have RMSD values 0.73 ± 0.30 Å and
1.26 ± 0.40 Å for backbone and heavy atoms, respectively. His110 and
His124 side chains are colored in blue and cyan, respectively. The ﬁgure
was created with MOLMOL 2.K.1.
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shown by potentiometric measurements (see Table 1C), the
deprotonation of lysine and tyrosine residues occurs at pH
around 9. This may strongly impact peptide interaction with
positive charged DTAC micelles, which in turn causes the
observed conformational changes.
Spectroscopic features of chPrP105–140 and Cu2+–
chPrP105–140 in the presence of SDS and DTAC micelles
All spectroscopic data including CD and UV-Vis experiments
are presented in Table 3.
The results obtained by spectroscopic studies (UV-Vis and
CD spectra) of chPrP105–140 in water, SDS and DTAC solutions
are shown in Fig. 5 and 6, respectively. The first absorptions in
the UV-Vis and CD spectra appear at diﬀerent pH values
according to the investigated system. In particular, the first
band at 580 nm is observed at pH 5.5 in the case of water and
DTAC solutions, while in the presence of SDS, a pH increase of
about 0.5–1.0 unit is necessary to observe the first band. This
behavior is in agreement with potentiometric data showing
that the pK values for the complex formed in SDS solutions are
higher than those found for the analogues species in water
and DTAC solutions.
In water and DTAC solutions, a UV-Vis band at 580 nm
(Fig. 5A and C) is visible at pH around 5.50 (CuH4L is the main
species). At this pH, on the CD spectra, we also observed d–d
bands at 503 and 580 nm, respectively (Fig. 6A and C). These
values support a 3N donor set {1Nim, 2N
−}. The involvement of
imidazole and amide nitrogens is also confirmed by the
characteristic charge transfer transitions detected in CD
spectra (Fig. 6A and C) which are in the 310–315 nm range for
N− → Cu2+ (ligand to metal charge transfer LMCT transitions
originating from amide nitrogens to Cu2+) or in the
280–345 nm for Nim → Cu
2+ (one LMCT transition originating
from the π1 orbital of the imidazole ring to Cu2+)
absorptions.57–62 The CuH3L species, which dominates at pH
around 6.2 (Fig. 1A and C), has a {1Nim, 2N
−} copper binding
mode as well, in fact we do not observe any significant
changes on the CD and UV-Vis spectra. In water and DTAC
solutions, CuH2L complexes are the main species at physio-
logical pH (Fig. 1A and C). Spectrophotometric data recorded
at that pH show the shift of the d–d band from 580 to 558 nm
(Fig. 5A and C), strongly supporting a {Nim, 3N
−} binding
mode.17,18,25,63,64 At physiological pH, the CD d–d bands at
534 and 644 nm (Fig. 6A and C) indicate additional amide
coordination. This coordination mode is also conserved at
higher pH (8–11), where the UV-Vis d–d bands at 550–530 nm
support a 4N donor set. Additionally, the distribution of d–d
bands on CD spectra does not change (Fig. 6A and C) confirm-
ing the {1Nim, 3N
−} binding mode.
On the other hand, in the case of SDS, the CuH3L is the
dominant species at physiological pH (Fig. 1B). At pH 7, CD
spectra have (i) a positive band in a 300–360 nm range which
is commonly assigned to charge transfer transitions, like
N− → Cu2+ and Nim → Cu
2+ and (ii) positive and negative tran-
sition bands at 490 and 590 nm, respectively (Fig. 6B). A diﬀerent
distribution of the d–d band is also observed in UV-Vis spectra
Table 3 Spectroscopic parameters for Cu2+–chPrP105–140 complex
formation. Metal to ligand ratio 1 : 1.2. [Cu2+] = 0001 M
Species
UV-Vis CD
λ [nm] ε [cm−1 M−1] λ [nm] Δε [cm−1 M−1]
H2O
CuH6L
CuH5L 581 39.76 590 −3.67
501 1.46
337.5 9.25
305 −9.90
CuH4L 566 59.13 591 −5.66
501.5 1.50
334.5 9.02
304 −8.16
CuH3L 563 72.68 718.5 2.25
569 −5.34
328.5 9.38
304.5 −2.51
CuH2L 554 91.63 643.5 13.31
532.5 −15.29
320.5 17.07
CuHL 549 106.78 639.5 18.36
534 −19.68
320 20.92
CuL 540 118.49 639 19.82
530 −20.61
321.5 22.37
CuH−1L 535 139.82 642 20.95
534 −22.11
318.5 23.03
CuH−2L 529 141.69 641 21.40
533.5 −23.48
318 22.02
SDS
CuH6L
CuH5L
CuH4L 577 55.42 596 −3.41
478 1.17
335.5 13.95
CuH3L 555 97.44 586 −6.87
487 1.73
337 18.60
CuH2L 550 116.04 566 −9.36
487 2.69
328 15.06
CuHL 538 144.68 653 8.27
548 −15.47
324 19.40
CuL 529 150.55 649 12.99
543 −18.86
323 22.64
CuH−1L 648.5 15.85
543 −22.96
321.5 22.47
CuH−2L
DTAC
CuH6L
CuH5L 565 32.60 595.5 −4.62
338 7,0
304 −11.03
CuH4L 567 50.48 589 −7.37
502 0.50
334.5 8.47
304.5 −11.04
CuH3L 563 66.82 701 1.12
568.5 −6.93
331 8.49
305.5 −5.30
CuH2L 559 74.64 658 5.91
547.5 −10.20
326 11.61
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compared to the one recorded in water and DTAC solutions
(Fig. 5B). This behavior is consistent with diﬀerent donor sets,
which takes into account the involvement of both His imid-
azole nitrogens.
In order to obtain more information on the copper(II)–
chPrP105–140 coordination mode at physiological pH, we also
carried out EPR experiments. The results obtained from EPR
Table 3 (Contd.)
Species
UV-Vis CD
λ [nm] ε [cm−1 M−1] λ [nm] Δε [cm−1 M−1]
CuHL 545 88.83 643 17.33
537.5 −21.24
322 20.01
CuL 544 93.73 638.5 17.99
537 −22.77
323 21.23
CuH−2L 542 90.54 634.5 17.89
535.5 −22.28
324 22.22
Fig. 5 UV-Vis spectra of Cu2+–chPrP105–140 in water (A), SDS (B) and
DTAC (C) solutions in a 1 cm quartz cell. 1 : 1.2 Cu2+/peptide ratio; T =
298.2; cpeptide = 1 × 10
−3 M.
Fig. 6 CD spectra for Cu2+ complexes of the chPrP105–140 in (A)
water, (B) SDS and (C) DTAC solutions in a 1 cm quartz cell. 1 : 1.2 Cu2+/
peptide ratio; T = 298.2; cpeptide = 1 × 10
−3 M.
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spectra are in agreement with those derived from potentio-
metric titrations, UV-Vis and CD spectroscopy. At physiological
pH, the copper coordination sphere consists of four nitrogen
atoms either in water (AII = 197.5, gII = 2.20) (Fig. 7A) or DTAC
solutions (AII = 200, gII = 2.20) (Fig. 7C), as indicated by the
EPR parameters. In the case of SDS, EPR spectra is broadened,
probably due to the eﬀect of the detergent, nevertheless it was
possible to define EPR parameters. In SDS solutions, at pH
7.20, the copper ion is anchored by two imidazole nitrogen
atoms from histidine residues and one backbone amide nitro-
gen forming a 3N binding mode (Fig. 7B). Above pH 8,
additional amide is bound causing the formation of the 4N
complex {2Nim, 2N
−} (Fig. 7B). Interestingly, the EPR spectrum
for the complex in SDS at pH 7.20 shows the presence of two
diﬀerent species. One is predominant and was described
above (3N binding mode), but it was also possible to deter-
mine EPR parameters for the second (AII = 157.5, gII = 2.28),
which indicate a 2N coordination sphere (less nitrogen
content in the equatorial coordination shell). This might rep-
resent a Cu2+ ion bound to the two His residues, one of them
being one (H111) inserted in the α-helical structure. The distri-
bution diagram (Fig. 1B) clearly shows that at pH 7.20 two
species occur (CuH3L and CuH2L), but the predominant one is
CuH3L, which indicates that three nitrogen atoms are involved
in the copper coordination sphere (3N).
The progressive decrease of hyperfine splitting passing
from EPR spectra in water, DTAC and SDS solutions supports a
major involvement of amide nitrogen atoms in water and
DTAC compared to SDS, where the binding of His imidazole is
preferred. Nevertheless, comparing the EPR spectra at physio-
logical pH (Fig. 5S†), we noticed that SDS micelles cause the
simultaneous presence of diﬀerent metal bound species.
Additionally, in all of the EPR measurement range (0–5000 G),
we do not observe any dimeric and bis-complex species.
In order to get more details of copper coordination to
chPrP in the presence of SDS micelles, the induced copper line
broadening eﬀects on NMR spectra were analyzed as well.
1H titration experiments, recorded by increasing metal concen-
tration, show that the most aﬀected signals belong to both His
(His110 and His124) and Tyr109 residues (Fig. 8). Upon the
addition of 0.2 Cu2+ eq., their intensities decrease and comple-
tely vanish in the presence of a higher amount of the para-
magnetic ions. Similar results are evident by comparing the
1H–1H TOCSY spectra of chPrP105–140 in the absence and in
the presence of Cu2+ ions (Fig. 9). The cross-peaks belonging
to Tyr109 and His110 are so broadened and can hardly be
observed. Eﬀects on Trp115 and His124 are visible as well.
These findings strongly support metal binding to both His
imidazoles. In addition the eﬀects detected on the Tyr109 aro-
matic ring suggest its stabilizing role on copper complexation,
similarly to what was observed in water solutions.39,65
Cu2+ binding to chPrp105–133 in water was extensively
investigated some years ago,39 the reported results indicated
Fig. 7 X-band EPR spectra of 1 : 1.2 Cu2+–chPrP105–140 frozen (A)
water, (B) SDS and (C) DTAC solutions. cpeptide = 1 × 10
−3 M.
Fig. 8 Superimposition of the aromatic region of 1H 1D NMR spectra of
chPrP105–140, at pH 7.2, SDS 40 mM, T = 298.0 K, in the absence
(black trace) and in the presence of 0.2 Cu2+ eq. (blue trace), 0.4 Cu2+
eq. (magenta trace), 0.8 Cu2+ eq. (green trace).
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that the main copper binding site at physiological pH is
located at His110 and it has a {Nim, 3N
−} donor set. Our find-
ings are in good agreement with this study. However, the com-
parison of the thermodynamic parameters obtained for the
two copper complexes points out that the longest peptide,
chPrP105–140, is a stronger ligand for Cu2+ in all of the pH
range (Fig. 10), suggesting that the hydrophobic tail plays
some stabilization eﬀect on metal ion binding. Finally we com-
pared the copper binding ability of human (hPrP91–127)47 and
chicken (chPrP105–140) systems. Our findings indicate that
chPrP105–140 is a better copper ligand than hPrP91–127 both
in water and SDS solutions (Fig. 11). The chPrP105–140 frag-
ment binds about 70% of Cu2+ at physiological pH. This be-
havior is possibly due to copper interaction with the aromatic
ring of Tyr109, absent in the human PrP amyloidogenic
sequence.
Conclusions
Prion proteins do not only occur in mammalian species. They
are present in avians, fishes, reptiles and amphibians. Both
hPrP91–127 and chPrP105–140 amyloidogenic regions strongly
bind Cu2+ ions. For both systems His residues act as indepen-
dent anchoring sites for metal coordination. The two binding
modes are diﬀerently populated, being the N-terminal and
C-terminal imidazoles the preferred binding domain for avian
and human PrP respectively.17,39,40 On the other hand, we
recently investigated that both His residues are contempora-
neously coordinated to Cu2+ ions when hPrP91–127 interacts
with SDS micelles.47
In the present paper, we have studied copper(II) binding to
the chPrP105–140 fragment to clarify the role played by the
Fig. 9 Selected region of 1H–1H TOCSY spectra of chPrP105–140
0.5 mM pH = 7.5, SDS 40 mM, T = 298, before (black) and after the
addition of 0.2 equivalents of Cu2+ (pink).
Fig. 10 Competition diagram between Cu2+–chPrP105–140 and
Cu2+–chPrP105–133 complexes. [Cu2+] = [chPrP105–140] =
[chPrP105–133] = 1 × 10−3 M.
Fig. 11 Competition diagram between Cu2+–chPrP105–140 and Cu2+–
hPrP91–127 complexes in (A) H2O solution and (B) SDS micelles.
[Cu2+] = [chPrP105–140] = [hPrP91–127] = 1 × 10−3 M.
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two His residues (H110 and H124) in the presence of anionic
and cationic micelles. In fact, the metal binding mode
observed at the N-terminal site (His110) might not be per-
turbed by SDS interaction at the C-terminal region. However,
our findings clearly indicate that, for hPrP91–127, simul-
taneous or independent Cu2+ coordination His is strongly
dependent on the α-helix conformation of the amyloidogenic
PrP regions. At physiological pH, CD and UV-Vis absorption
spectroscopy strongly support a {Nim, 3N
−} binding mode in
water and DTAC solutions (random coil) while a {2Nim, 2N
−}
copper donor set is suggested in SDS solutions (α-helix). The
main chain nitrogens bound to copper belong to residues
close to His110 imidazole, like His110 and Tyr109 amides. In
fact, the rigid α-helix rearrangement around His124, probably
hampers the binding of amide nitrogens which require the for-
mation of five membered macrochelate rings.
In SDS micelles, near UV CD spectra and NMR analysis
show nice helicoidal structuring of the peptide backbone
(elements between residues 120–131), while in water
solution, chPrP105–140 systems have CD spectra characterized
by random coil conformation. The same results were
observed for human analogues. Additionally, cationic micelles
also cause the formation of the α-helix structure but at pH
above 9.
One of the visible diﬀerences between human and chicken
amyloidogenic sequences is the presence of a tyrosine residue
in the chPrP105–140 fragment (Scheme 1). Our NMR findings
point out that the most aﬀected signals belong to both His
(His110 and His124) and Tyr109 residues. The eﬀects observed
on the Tyr109 aromatic ring suggest its stabilizing role on
copper ion binding and might explain the higher stability of
chicken protein fragment complexes detected at pH higher
than 5.5 (Fig. 11).
By bearing in mind that (i) the hPrP amyloidogenic region,
considered critical for PrPC–PrPSc conformational transition, is
highly conserved in chPrP and (ii) copper binding to the
His111 site of the hPrP amyloidogenic region reduces the
natural tendency of apo peptides to adopt β-sheet confor-
mation, which on the contrary is stabilized by multi His
binding,66 we might hypothesize a diﬀerent impact of Cu2+ on
hPrP and chPrP aggregation propensities according to the
protein environment. Upon SDS interaction, Cu2+ coordination
to both His sites might lead to the formation of a hairpin
structure in both peptides, which in turn might stabilize the
β-sheet structure. On the other hand, the diﬀerent preferred
His anchoring points found in hPrP and chPrP water solutions
might result in diﬀerent eﬀects.39 The close proximity of the
His binding site to the hydrophobic region in hPrP only, might
induce diﬀerent conformational changes in the two proteins,
favoring or disfavoring the formation of fibrillar structures.
Interestingly, a comparison between the thermodynamic
parameters obtained for the two copper complexes of
chPrP105–133 and chPrP105–140 respectively, reveal that the
longest peptide is a stronger ligand for Cu2+ for the whole pH
range. This suggests that the hydrophobic tail may play some
stabilization eﬀect on metal ion binding.
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